PRODUCT LITERATURE

Glimepiride : A Review of its Use in the Management of Type 2 Diabetes Mellitus

---

Glimepiride is a sulphonylurea agent that stimulates insulin release from pancreatic b-cells and may act via extrapancreatic mechanisms. It is administered once daily to patients with type 2 (non–insulin-dependent) diabetes mellitus in whom glycaemia is not controlled by diet and exercise alone, and may be combined with insulin in patients with secondary sulphonylurea failure

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Gluvas
Glimepiride
Type 2 Diabetes Mellitus

Specific Detail Info

Drugs 1998 Apr 55 (4): 563-584

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment